Dr. Ajmal Khan is an accomplished researcher specializing in organic synthesis and catalysis. Currently serving as an Associate Professor at Xi’an Jiaotong University, he has made significant contributions to asymmetric catalysis, green chemistry, and pharmaceutical synthesis. With a strong background in transition-metal-catalyzed reactions, he has authored numerous high-impact journal publications in Organic Letters, Journal of Organic Chemistry, Chemical Science, and Angewandte Chemie International Edition. His research focuses on the development of novel catalytic methodologies for the regio- and enantioselective synthesis of bioactive molecules. Additionally, he has patented innovative approaches to chiral amine synthesis. Despite his extensive publication record, Dr. Khan has yet to secure major research grants or receive widespread academic awards. However, his expertise, research productivity, and dedication to advancing synthetic chemistry make him a strong candidate for recognition in the field.

Professional Profile

• Scopus Profile
• ORCID Profile

Education

Dr. Ajmal Khan has a strong academic background in chemistry. He earned his Ph.D. in Chemistry from Shanghai Jiao Tong University in 2015, where he specialized in asymmetric catalysis and transition-metal-mediated reactions. Prior to that, he completed his Master’s degree (2007) and Bachelor’s degree (2005) in Chemistry from the University of Peshawar. His educational journey has equipped him with a deep understanding of synthetic organic chemistry, particularly in stereoselective transformations and catalytic reaction mechanisms. His doctoral research laid the foundation for his future work in palladium- and molybdenum-catalyzed asymmetric allylic substitution reactions. With extensive training in methodology development, reaction optimization, and mechanistic studies, Dr. Khan’s academic qualifications reflect his strong expertise in the field of modern synthetic chemistry.

Professional Experience

Dr. Ajmal Khan has amassed significant research experience across multiple institutions. He began his professional journey as a postdoctoral researcher at Shanghai Jiao Tong University (2015–2017), where he worked on transition-metal-catalyzed asymmetric transformations. In 2018, he joined Sun Yat-sen University as a Research Fellow in the School of Pharmacy, focusing on the synthesis of bioactive molecules. Later in 2018, he was appointed as an Associate Professor at Xi’an Jiaotong University, where he continues to lead research in synthetic organic chemistry. Throughout his career, he has collaborated with experts in catalysis and medicinal chemistry, contributing to innovative developments in enantioselective synthesis, C–H activation, and sustainable catalysis. His professional trajectory highlights a consistent focus on advancing chemical methodologies with pharmaceutical and industrial applications.

Research Interests

Dr. Ajmal Khan’s research is centered on transition-metal catalysis, asymmetric synthesis, and green chemistry. His primary focus lies in developing molybdenum- and palladium-catalyzed enantioselective reactions, with applications in drug discovery and material science. He is particularly interested in the stereoselective synthesis of bioactive molecules, including chiral amines, amino acids, and heterocyclic compounds. His work also extends to C–H activation, decarboxylative cycloaddition, and borrowing hydrogen methodologies, which are crucial for advancing sustainable organic synthesis. Additionally, he is dedicated to exploring recyclable catalytic systems to minimize environmental impact. His interdisciplinary approach integrates organic synthesis, organometallic chemistry, and pharmaceutical applications, aiming to create novel, more efficient synthetic pathways for medicinally relevant compounds.

Research Skills

Dr. Ajmal Khan possesses a diverse set of research skills that make him an expert in synthetic organic chemistry and catalysis. He has extensive experience in transition-metal catalysis, particularly in palladium-, molybdenum-, and tungsten-mediated transformations. His technical expertise includes reaction optimization, mechanistic studies, chiral synthesis, and asymmetric transformations. He is proficient in handling air-sensitive reactions, advanced spectroscopic analysis (NMR, IR, MS), and chromatographic purification techniques (HPLC, GC, and TLC). Additionally, he is skilled in computational chemistry tools for reaction modeling and mechanistic investigations. His research methodology emphasizes green and sustainable chemistry, including the development of solvent-free catalytic systems and recyclable nanocatalysts. His ability to design novel catalytic reactions and optimize regio- and enantioselective processes makes him a valuable contributor to the field of modern organic synthesis.

Awards and Honors

Dr. Ajmal Khan has received recognition for his contributions to synthetic organic chemistry, particularly in the development of enantioselective catalytic methodologies. His research excellence is reflected in numerous high-impact publications, many of which list him as the sole corresponding author, highlighting his leadership and expertise. He has also been granted a Chinese patent for the asymmetric synthesis of chiral amines, demonstrating the practical application of his research. Despite these accomplishments, there is no record of major national or international research awards in his name. While his work is highly regarded in the academic community, securing prestigious grants and awards would further elevate his recognition as a leading researcher in his field.

Conclusion

Dr. Ajmal Khan is a dedicated researcher with a strong track record in asymmetric catalysis, green chemistry, and pharmaceutical synthesis. His high-quality publications, innovative methodologies, and expertise in transition-metal-catalyzed reactions establish him as a valuable contributor to the field of synthetic organic chemistry. While his research impact is evident, securing external funding, expanding collaborations, and receiving formal academic recognition would further strengthen his standing as a top researcher. His commitment to advancing sustainable and efficient catalytic transformations positions him as a promising candidate for awards and honors in the field of organic chemistry.

Publications Top Notes

1. Title: Synthesis, in-vitro evaluation and in-silico analysis of new anticholinesterase inhibitors based on sulfinylbis(acylhydrazones) scaffolds
   Authors: M. Ibrahim Muhammad, M.Z. Ali Mumtaz Z., S.A.S.A. Halim Sobia Ahsan Syed Abd, A.L. Khan Ajmal L., A.S. Al-Harrasi Ahmed Sulaiman
   Year: 2025

2. Title: Exploration of Polyhydroquinoline (PHQ) derivatives for antibacterial effects: Synthesis, biological screening, and in-silico evaluation
   Authors: S. Hussain Sajid, A. Latif Abdul, M.Z. Ali Mumtaz Z., A.S. Al-Harrasi Ahmed Sulaiman, F.A. Özdemir Fethi Ahmet
   Year: 2025

3. Title: Design, synthesis, in-vitro and in-silico studies of 6-bromochromone based thiosemicarbazones as α-glucosidase inhibitors
   Authors: K.A. Dahlous Kholood Ahmed, M.M. Ajmal Muhammad Maroof, S.A. Ullah Saeed Aqib, A.S. Al-Harrasi Ahmed Sulaiman, Z. Shafiq Zahid
   Year: 2025

4. Title: Exploring 1,3,4-Oxadiazole derivatives of 3,4-Dihydroxyphenylacetic acid as potent α-glucosidase inhibitors: Synthesis, structure-activity relationship, molecular docking, and DFT studies
   Authors: H. Khan Hammad, F. Jan Faheem, Aqsa, M. Khan Momin, S. Ali Shaukat
   Year: 2025

5. Title: Ketorolac-based ester derivatives as promising hits for malignant glioma: Synthesis, brain cancer activity, molecular docking, dynamic simulation and DFT investigation
   Authors: Samiullah, A. Alam Aftab, Zainab, A.S. Al-Harrasi Ahmed Sulaiman, M.M. Ahmad M.M.
   Year: 2025

6. Title: Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
   Authors: M. Ng Marie, E. Gakidou Emmanuela, J. Lo Justin, M. Al-Wardat Mohammad, Y.M. Al-Worafi Yaser Mohammed
   Year: 2025
   Citations: 2

7. Title: Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
   Authors: J.A. Kerr Jessica A., G.C. Patton George C., K.I. Cini Karly I., F.J. Alvi Farrukh Jawad, N.R. Alvis-Guzman Nelson Rafael
   Year: 2025
   Citations: 2

8. Title: Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
   Authors: N. Steel N., C.M.M. Bauer-Staeb Clarissa Maria Mercedes, J.A. Ford John A., N.B. Bhala Neeraj B., S.M. Bhaskar Sonu M.M.
   Year: 2025

9. Title: Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
   Authors: N. Davis Weaver Nicole, G.J. Bertolacci Gregory J., E. Rosenblad Emily, O.P. Doshi Ojas Prakashbhai, H.L. Dsouza Haneil Larson
   Year: 2025

10. Title: Design, synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as α-glucosidase inhibitors
    Authors: R. Farooqi Rehmatullah, S.A. Ullah Saeed Aqib, A.L. Khan Ajmal L., Z. Shafiq Zahid, S. Schenone Silvia
    Year: 2025